192 related articles for article (PubMed ID: 37831068)
1. RNF185 Control of COL3A1 Expression Limits Prostate Cancer Migration and Metastatic Potential.
Van Espen B; Oo HZ; Collins C; Fazli L; Molinolo A; Yip K; Murad R; Gleave M; Ronai ZA
Mol Cancer Res; 2024 Jan; 22(1):41-54. PubMed ID: 37831068
[TBL] [Abstract][Full Text] [Related]
2. RNF185 control of COL3A1 expression limits prostate cancer migration and metastatic potential.
Van Espen B; Oo HZ; Collins C; Fazli L; Molinolo A; Murad R; Gleave M; Ronai ZA
bioRxiv; 2023 Jul; ():. PubMed ID: 37425866
[TBL] [Abstract][Full Text] [Related]
3. RNF185 antisense RNA 1 (RNF185-AS1) promotes proliferation, migration, and invasion in papillary thyroid carcinoma.
Liu D; Zhang M; Song Y; Yang N
Anticancer Drugs; 2022 Jul; 33(6):595-606. PubMed ID: 35324519
[TBL] [Abstract][Full Text] [Related]
4. RNF185 modulates JWA ubiquitination and promotes gastric cancer metastasis.
Qiu D; Wang Q; Wang Z; Chen J; Yan D; Zhou Y; Li A; Zhang R; Wang S; Zhou J
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1552-1561. PubMed ID: 29481911
[TBL] [Abstract][Full Text] [Related]
5. RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis.
Huang C; Li K; Huang R; Zhu J; Yang J
Life Sci; 2021 Feb; 267():118928. PubMed ID: 33358902
[TBL] [Abstract][Full Text] [Related]
6. The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI).
Sun Y; Jia X; Gao Q; Liu X; Hou L
IUBMB Life; 2017 Jan; 69(1):16-21. PubMed ID: 27862841
[TBL] [Abstract][Full Text] [Related]
7. RNF185 is a novel E3 ligase of endoplasmic reticulum-associated degradation (ERAD) that targets cystic fibrosis transmembrane conductance regulator (CFTR).
El Khouri E; Le Pavec G; Toledano MB; Delaunay-Moisan A
J Biol Chem; 2013 Oct; 288(43):31177-91. PubMed ID: 24019521
[TBL] [Abstract][Full Text] [Related]
8. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
[TBL] [Abstract][Full Text] [Related]
9. Long Noncoding RNA Small Nucleolar RNA Host Gene 3 Mediates Prostate Cancer Migration, Invasion, and Epithelial-Mesenchymal Transition by Sponging miR-487a-3p to Regulate
Yu L; Ren Y
Cancer Biother Radiopharm; 2022 Aug; 37(6):451-465. PubMed ID: 33416420
[No Abstract] [Full Text] [Related]
10. RNF185, a novel mitochondrial ubiquitin E3 ligase, regulates autophagy through interaction with BNIP1.
Tang F; Wang B; Li N; Wu Y; Jia J; Suo T; Chen Q; Liu YJ; Tang J
PLoS One; 2011; 6(9):e24367. PubMed ID: 21931693
[TBL] [Abstract][Full Text] [Related]
11. Leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial-mesenchymal transition.
Luo W; Tan P; Rodriguez M; He L; Tan K; Zeng L; Siwko S; Liu M
J Biol Chem; 2017 Sep; 292(37):15525-15537. PubMed ID: 28768769
[TBL] [Abstract][Full Text] [Related]
12. [MTBP regulates migration and invasion of prostate cancer cells
Xiao Z; Chen M; Yang J; Yang C; Lü X; Tian H; Liu C
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):6-12. PubMed ID: 30692060
[TBL] [Abstract][Full Text] [Related]
13. TRIM16 suppresses the progression of prostate tumors by inhibiting the Snail signaling pathway.
Qi L; Lu Z; Sun YH; Song HT; Xu WK
Int J Mol Med; 2016 Dec; 38(6):1734-1742. PubMed ID: 27748839
[TBL] [Abstract][Full Text] [Related]
14. Expression of Tripartite Motif-Containing Proteactiin 11 (TRIM11) is Associated with the Progression of Human Prostate Cancer and is Downregulated by MicroRNA-5193.
Pan Y; Zhang R; Chen H; Chen W; Wu K; Lv J
Med Sci Monit; 2019 Jan; 25():98-106. PubMed ID: 30608062
[TBL] [Abstract][Full Text] [Related]
15. The E3 ligase RNF185 negatively regulates osteogenic differentiation by targeting Dvl2 for degradation.
Zhou Y; Shang H; Zhang C; Liu Y; Zhao Y; Shuang F; Zhong H; Tang J; Hou S
Biochem Biophys Res Commun; 2014 May; 447(3):431-6. PubMed ID: 24727453
[TBL] [Abstract][Full Text] [Related]
16. TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR‑155.
Chen W; He LN; Liang Y; Zeng X; Wu CP; Su MQ; Cheng Y; Liu JH
Mol Med Rep; 2020 Dec; 22(6):5209-5218. PubMed ID: 33174061
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness.
Bizzarro V; Belvedere R; Migliaro V; Romano E; Parente L; Petrella A
Cell Adh Migr; 2017 May; 11(3):247-260. PubMed ID: 27834582
[TBL] [Abstract][Full Text] [Related]
18. circHECTD1 promotes the silica-induced pulmonary endothelial-mesenchymal transition via HECTD1.
Fang S; Guo H; Cheng Y; Zhou Z; Zhang W; Han B; Luo W; Wang J; Xie W; Chao J
Cell Death Dis; 2018 Mar; 9(3):396. PubMed ID: 29540674
[TBL] [Abstract][Full Text] [Related]
19. TRIM11 Posttranscriptionally Modulated by miR-5193 Facilitates Tumor Growth and Metastasis of Prostate Cancer.
Pan Y; Yu H; Lu F
Technol Cancer Res Treat; 2023; 22():15330338231178639. PubMed ID: 37248611
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]